Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > SYNBIOBETA SF 2013 The Conference For Synthetic Biology Startups, Industry and Investors

Abstract:
On November 15, 2013, SynBioBeta will once again be bringing together the synthetic biology community for the second annual SynBioBeta Conference at Mission Bay Conference Center UCSF.

SYNBIOBETA SF 2013 The Conference For Synthetic Biology Startups, Industry and Investors

San Francisco, CA | Posted on October 27th, 2013

The conference provides a venue for companies, both established and startups, investors and academics to meet, partner, exchange ideas and learn about the latest advances in the rapidly evolving field of synthetic biology. Some of the topics on the agenda are: Crowdfunding, Advances in Gene and Genome Synthesis, Scale-up in the Bioeconomy and Synthetic Biology VC Funding. The audience will also hear from new startups in the field, including nine companies visiting from the UK on a synthetic biology trade mission.

"We are now seeing an exponential growth in the number of synthetic biology startups year after year," says Dr. John Cumbers, founder of SynBioBeta. "As the cost of writing DNA falls, we see a range of new startup companies entering the synthetic biology market competing with a number of established players" "These companies range from those with new technologies for writing DNA such as Gen9 and DNA2.0, to companies making computer aided design (CAD) tools for genome design such as Teselagen, Genome Compiler and Benchling." "We also have a number of speakers from applications companies such as Dr. Paul Hill from Amyris, Dr. Harry Yim from Genomatica and Sean Ward from UK based Synthace, who will all be talking about scaling up their solutions for the production of high value chemicals. Dr. Mike Koeris from Sample6 technologies will also be giving an update on their innovative food safety biosensor, for which they just closed an $11M series B financing."

The conference will be followed by a cocktail reception and on Saturday, November 16, 2013, SynBioBeta will be presenting a Networking Brunch Cruise past the Golden Gate Bridge for anyone in the synthetic biology community to attend. For more information on the conference and the Brunch Cruise, please contact Lisa Comeau at 650-479-5011, or visit www.synbiobeta.com.

####

For more information, please click here

Contacts:
Lisa Comeau
Phone: 650-479-5011

Copyright © SynBioBeta, LLC

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

New Method Uses DNA, Nanoparticles and Top-Down Lithography to Make Optically Active Structures: Technique could lead to new classes of materials that can bend light, such as for those used in cloaking devices January 18th, 2018

Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock January 18th, 2018

Leti to Demo New Curving Technology at Photonics West that Improves Performance of Optical Components January 18th, 2018

Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock January 17th, 2018

Synthetic Biology

Synthetic protein packages its own genetic material and evolves computationally designed protein assemblies are advancing research in synthetic life and in targeted drug delivery December 15th, 2017

Report highlights opportunities and risks associated with synthetic biology and bioengineering November 22nd, 2017

Living computers: RNA circuits transform cells into nanodevices July 27th, 2017

In-cell molecular sieve from protein crystal February 14th, 2017

Announcements

New Method Uses DNA, Nanoparticles and Top-Down Lithography to Make Optically Active Structures: Technique could lead to new classes of materials that can bend light, such as for those used in cloaking devices January 18th, 2018

Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock January 18th, 2018

Leti to Demo New Curving Technology at Photonics West that Improves Performance of Optical Components January 18th, 2018

Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock January 17th, 2018

Events/Classes

Leti to Demo New Curving Technology at Photonics West that Improves Performance of Optical Components January 18th, 2018

21st International Conference on Advanced Nanoscience and Nanotechnology December 31st, 2017

Leti Will Demonstrate First 3D Anti-Crash Solution for Embedding in Drones: Fitted on a Mass-Market Microcontroller, 360Fusion Software Technology Detects any Dynamic Obstacle and Helps Guide Drones Away from Collisions December 15th, 2017

Leti to Demo Wristband with Embedded Sensors to Diagnose Sleep Apnea: APNEAband, Which Will Be Demonstrated at CES 2018, Also Monitors Mountain Sickness, Dehydration, Dialysis Treatment Response and Epileptic Seizures December 12th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project